To measure the serum cox 2 level ( inflammatory mediator) in healthy individuals and melasma patients and correlate with the severity of the disease
Not Applicable
- Conditions
- Health Condition 1: L811- Chloasma
- Registration Number
- CTRI/2024/05/067537
- Lead Sponsor
- Dr surya Bramara
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
18 years and above , patients of all gender , diagnosed with melasma clinically - MASI score indicating severity
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.to estimate the levels of COX2 serum levels in melasma patients <br/ ><br>2.To compare cox-2 levels in the serum in melasma patients and healthy controls <br/ ><br>Timepoint: 18 months
- Secondary Outcome Measures
Name Time Method To evaluate the disease severity in patients with melasma using <br/ ><br>MASI and Dermoscopy. <br/ ><br>To correlate the levels of serum Cox-2 with the disease severity of <br/ ><br>melasma.Timepoint: 18 months